4//SEC Filing
Holuka Eugene Myron 4
Accession 0001213900-24-070240
CIK 0001851484other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:06 PM ET
Size
5.5 KB
Accession
0001213900-24-070240
Insider Transaction Report
Form 4
Holuka Eugene Myron
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+150,000→ 150,000 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001678292
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:06 PM ET
- Size
- 5.5 KB